ProKidney Corp. (PROK)

ProKidney Corp. (PROK) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $695M; returns 1 day -1.4%, 1 week +6.0%, 1 year -55.8%.

ProKidney Corp. (PROK) is a clinical-stage biotechnology company focused on developing novel cell therapies for chronic kidney disease (CKD).

Groups PROK belongs to

• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Autologous Cell Therapy
• Nephrology
• Regenerative Medicine
• Life Sciences
• Clinical Stage
• Chronic Disease Management
• Personalized Medicine

PROK financial model: income statement, cash flow and balance sheet